Literature DB >> 23278343

Non/infectious corporealities: tensions in the biomedical era of 'HIV normalisation'.

Asha Persson1.   

Abstract

In the contemporary HIV epidemic, antiretroviral treatments are increasingly considered so effective at viral suppression that they render people with HIV sexually non-infectious. With its radical implications for global HIV prevention, this emerging paradigm is invested with the potential to turn the epidemic around and to 'normalise' one of the most feared infectious diseases in history, thus echoing wider trends of 'biomedicalisation'. What remains unexamined is whether this paradigm shift will bring about a parallel shift in the embodied experiences of being HIV-positive. This article explores the nascent trajectory from infectious to non-infectious corporeality against the backdrop of the discursive history of HIV, with particular focus on the landmark Swiss Consensus Statement, and in the context of research with heterosexuals with HIV in Australia. In-depth interviews revealed that HIV corporeality was not a stable, homogenised experience across participants and time, nor did it simply follow medical discourses. Instead, HIV corporeality emerged as a contingent set of tensions between conflicting discourses of infectiousness that were negotiated and made sense of within situated and embodied life histories. These findings pose challenges to the imperative of HIV normalisation and the related tendency in HIV prevention to universalise the notion of 'infectiousness'.
© 2012 The Author. Sociology of Health & Illness © 2012 Foundation for the Sociology of Health & Illness/John Wiley & Sons Ltd. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  HIV corporeality; HIV normalisation; biomedicalisation; discourses of infectiousness; treatment-as-prevention

Mesh:

Substances:

Year:  2012        PMID: 23278343     DOI: 10.1111/1467-9566.12023

Source DB:  PubMed          Journal:  Sociol Health Illn        ISSN: 0141-9889


  18 in total

1.  Rethinking the Poverty-disease Nexus: the Case of HIV/AIDS in South Africa.

Authors:  Kiran Pienaar
Journal:  J Med Humanit       Date:  2017-09

2.  "So far it's been choosing which side effects I want or I can deal with": A grounded theory of HIV treatment side effects among people living with HIV.

Authors:  Marilou Gagnon; Dave Holmes
Journal:  Aporia       Date:  2016-01-01

3.  HIV normalization message and its implication on the lives of perinatally HIV-infected youth in Puerto Rico.

Authors:  Georgina Silva-Suárez; Silvia E Rabionet; Carmen D Zorrilla
Journal:  J Pharm Health Serv Res       Date:  2017-08-31

4.  What constitutes the best sex life for gay and bisexual men? Implications for HIV prevention.

Authors:  Adam Bourne; Gary Hammond; Ford Hickson; David Reid; Axel J Schmidt; Peter Weatherburn
Journal:  BMC Public Health       Date:  2013-11-20       Impact factor: 3.295

Review 5.  Pharmaceutical HIV prevention technologies in the UK: six domains for social science research.

Authors:  Peter Keogh; Catherine Dodds
Journal:  AIDS Care       Date:  2015-01-03

6.  Body-drug assemblages: theorizing the experience of side effects in the context of HIV treatment.

Authors:  Marilou Gagnon; Dave Holmes
Journal:  Nurs Philos       Date:  2016-07-20       Impact factor: 1.279

7.  How HIV patients construct liveable identities in a shame based culture: the case of Singapore.

Authors:  Lai Peng Ho; Esther C L Goh
Journal:  Int J Qual Stud Health Well-being       Date:  2017-12

8.  Clinical ethics issues in HIV care in Canada: an institutional ethnographic study.

Authors:  Chris Kaposy; Nicole R Greenspan; Zack Marshall; Jill Allison; Shelley Marshall; Cynthia Kitson
Journal:  BMC Med Ethics       Date:  2017-02-06       Impact factor: 2.652

9.  Moral practices shaping HIV disclosure among young gay and bisexual men living with HIV in the context of biomedical advance.

Authors:  Willa Dong; Kathryn E Muessig; Kelly A Knudtson; Adam Gilbertson; Stuart Rennie; Karina Soni
Journal:  Cult Health Sex       Date:  2020-08-04

10.  Can a pill prevent HIV? Negotiating the biomedicalisation of HIV prevention.

Authors:  Ingrid Young; Paul Flowers; Lisa McDaid
Journal:  Sociol Health Illn       Date:  2015-10-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.